Showing 2371-2380 of 2527 results for "".
- Foundation Fighting Blindness to Host Annual Retinal Cell & Gene Therapy Innovation Summit Before ARVOhttps://modernod.com/news/foundation-fighting-blindness-to-host-annual-retinal-cell-gene-therapy-innovation-summit-before-arvo/2476488/The Foundation Fighting Blindness will co-host the 6th annual Retinal Cell and Gene Therapy Innovation Summit, in partnership with the Casey Eye Institute at Oregon Health & Science University. The summit–one of the world’s most comprehensive reviews (three dozen presenters) of ongoing
- UCLA: Eliminating Routine Preoperative Tests for Cataract Surgery Associated With Cost Savingshttps://modernod.com/news/ucla-eliminating-routine-preoperative-tests-for-cataract-surgery-associated-with-cost-savings/2476480/UCLA researchers found that eliminating routine but unnecessary procedures before people undergo cataract surgery has the potential to save costs and resources for hospitals serving lower-income patients, according to a news release. Forgoin
- Ophthotech Changes Name to Iveric bio as it Transitions to Gene Therapy Companyhttps://modernod.com/news/ophthotech-changes-name-to-iveric-bio-as-it-transitions-to-gene-therapy-company/2476473/Ophthotech announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IRDs) with unmet medical needs, the company
- Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseaseshttps://modernod.com/news/ophthotech-obtains-exclusive-global-license-to-aav-gene-therapy-program-for-best1-related-retinal-diseases/2476467/Ophthotech announced that the company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania, including the Perelman School of Medicine at the University of Pennsylvania and the University of Pennsylvania School of Veterinary Medicine,
- NovaBay Pharmaceuticals Announces New Partner Pharmacy Programhttps://modernod.com/news/novabay-pharmaceuticals-announces-new-partner-pharmacy-program/2476465/NovaBay Pharmaceuticals announced a new pharmacy partnering program in an effort to ensure all patients in the United States have reliable and affordable access to prescription Avenova, according to a company news release. NovaBay has recently added six new pharmacies as Avenova channel partners.
- US Ophthalmologists Push to Remove Roadblocks to Patients’ Access to Medical and Surgical Eye Carehttps://modernod.com/news/us-ophthalmologists-push-to-remove-roadblocks-to-patients-access-to-medical-and-surgical-eye-care/2476461/More than 400 eye physicians and surgeons from across the United States are in Washington, DC, to urge Congress to end federal policies that delay patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the American Academy of Ophthalmology (AAO) is
- Texas Tech Medical School to End Use of Race in Admissionshttps://modernod.com/news/texas-tech-medical-school-to-end-use-of-race-in-admissions/2476462/Texas Tech University’s medical school has agreed to end its consideration of race in selecting candidates for admission, an outcome actively sought by the Trump administration. The Texas Tech University Health Sciences Center submitted to pressure from the Education Department’s Offi
- Alcon Launches Project Presbyopia to Educate Eye Care Providers and Consumers During Presbyopia Awareness Monthhttps://modernod.com/news/alcon-launches-project-presbyopia-to-educate-eye-care-providers-and-consumers-during-presbyopia-awareness-month/2476460/Alcon is launching Project Presbyopia as part of Presbyopia Awareness Month in April. Project Presbyopia is an ongoing effort to educate consumers about how to recognize signs and symptoms of vision changes, uncover more intuitive language for the condition, and drive existing and emerging presby
- Alcon Debuts as Independent, Publicly Traded Companyhttps://modernod.com/news/alcon-debuts-as-independent-publicly-traded-company/2476453/After 8 years under Novartis ownership, Alcon is officially an independent, publicly traded company. On Tuesday, Alcon completed its separation from Novartis and its shares begin trading on the SIX Swiss Exchange and New York Stock Exchange under the symbol “ALC.” American depositary recei
- A Soft Spot for Stem Cells Helps Cornea Healinghttps://modernod.com/news/a-soft-spot-for-stem-cells-helps-cornea-healing/2476436/New research led by scientists at Newcastle University, UK, reveals a potential revolutionary way to treat eye injuries and prevent blindness—by softening the tissue hosting the stem cells which then helps repair wounds inside the body. The team discovered that the simple application of a